Male Infertility Market Research Strategies by Key Drivers, 2023 to 2028
-
Industry Overview of Male Infertility Market
Male infertility reduces the likelihood of an affected individual's ability to conceive with a fertile woman. This condition can arise due to abnormal sperm function, blockages, or low sperm production, which hinders the delivery of sperm. Factors like genetic defects, undescended testicles, lifestyle choices, diabetes, and infections (such as chlamydia, gonorrhea, mumps, HIV, etc.) are common culprits behind male infertility. Effective treatments for male infertility encompass vasoepididymostomy, hormone therapy, and assisted reproductive technology (ART) procedures like in vitro fertilization (IVF) and varicocele surgery. These interventions work to improve male reproductive health, restore testosterone levels, enhance sperm quality, and facilitate successful pregnancy.
How Big Is the Male Infertility Market?
The global male infertility market size reached US$ 3.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach a value of US$ 5.2 Billion by 2028 exhibiting a CAGR of 5.49% during 2023-2028.
Global Male Infertility Market Trends and Drivers:
The male infertility market is experiencing notable growth, driven by various factors. The increasing prevalence of delayed pregnancies and evolving lifestyles are key drivers behind this growth. Furthermore, the adoption of DNA fragmentation techniques and computer-assisted semen analysis to diagnose conditions like hypospermia is boosting the market. The rising demand for assisted reproductive technology (ART) procedures, including IVF, which often involve using cryopreserved sperm, is positively impacting the global market. Additionally, government initiatives to enhance reimbursement for infertility treatments and ensure patient data safety contribute to growth. The availability of diverse infertility treatment options, drugs, and devices also plays a role in stimulating the market. Improved healthcare accessibility is expected to further fuel the male infertility market in the forecasted period.
Key Market Segmentation:
The report provides detailed segmentation of the global male infertility market based on based on test type, treatment, distribution channel, end user and industry vertical.
Breakup by Test Type:
Sperm Agglutination
DNA Fragmentation Technique
Oxidative Stress Analysis
Computer Assisted Semen Analysis
Sperm Penetration Assay
OthersBreakup by Treatment:
Medication
Assisted Reproductive Technology and Varicocele SurgeryBreakup by Distribution Channel:
Hospitals Pharmacies
Pharmacies and Drug Stores
Online PharmaciesBreakup by End User:
Hospitals and Clinics
Fertility Centers
Research Institutes
OthersBreakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and AfricaThe report provides a comprehensive analysis of the industry key players listed below:
The Major Players in the market are Andrology Solutions, CinnaGen Co., Halotech DNA, SCSA Diagnostics Inc., Vitrolife, Zydus Lifesciences Limited, Intas Pharmaceuticals Ltd. and Endo International plc.